2. KFDA Medical Device Registration Framework: What Korean ISBM Packaging Producers Need to Know

Korean KFDA classifies medical devices under the 의료기기법 (Medical Device Act) into four classes based on risk level. The classification determines the approval pathway and, critically for packaging producers, the depth of manufacturing documentation and validation required. Korean ISBM packaging producers must understand which class their customer’s device falls under — because the packaging manufacturer’s GMP obligations are driven by the device class, not by the packaging manufacturer’s own classification.

Korean Class I medical devices (신고품목) cover low-risk devices and accessories including general sample collection vessels, Class I specimen cups, and packaging for non-sterile non-contact accessories. Korean ISBM containers for Class I applications require only basic material identification (resin grade, colour masterbatch lot), dimensional records (neck OD, bottle height, weight), and food contact positive list confirmation. Korean ISBM producers already meeting Korean food contact packaging standards can supply Class I medical device containers with minimal additional documentation investment.

Korean Class II medical devices (인증품목) cover moderate-risk IVD reagent containers, diagnostic kit components, wash solution bottles, and clinical specimen storage containers. Korean ISBM packaging for Class II requires ISO 10993 biocompatibility evaluation (cytotoxicity minimum), material traceability to specific lot and grade, dimensional qualification certificate from each cavity, and GMP batch record retention. The Korean notified body (인증기관) that certifies the device manufacturer reviews the packaging manufacturer’s quality documentation as part of the device certification audit — making packaging GMP documentation a direct prerequisite for the medical device customer’s KFDA certification.

Korean Class III and IV medical devices (허가품목) covering drug delivery systems, sterile device contact surfaces, and life-sustaining device packaging require the most complete Korean ISBM manufacturing validation: full ISO 10993 biocompatibility series (typically ISO 10993-5 cytotoxicity, ISO 10993-10 sensitisation, ISO 10993-12 sample preparation), extractables and leachables (E&L) study, GMP IQ/OQ/PQ validation, sterilisation validation (if the container is sterilised after filling), and KFDA primary container registration under the device’s 허가 (approval) dossier. Korean ISBM producers entering Class III/IV supply must plan a 6–12 month qualification timeline and KRW 25–55M validation investment before first commercial delivery.

3. Material Selection: PET, PETG, and PP for Korean Medical Device Containers

Material selection for Korean ISBM medical device containers is driven by three factors: chemical compatibility with the specific reagent or device content, sterilisation method compatibility, and regulatory compliance. Unlike Korean K-Beauty applications where PETG is the preferred material for aesthetics, Korean medical device applications require deliberate material analysis before selection — PETG, PET, and PP each have specific strengths and limitations that determine their suitability for different device categories.

PET for Korean medical devices: PET (polyethylene terephthalate) is the most widely used Korean ISBM material for Class I and II medical device containers. Its advantages are low extractables at ambient storage temperatures (well-characterised by ISO 10993-17 for risk assessment), broad chemical compatibility covering aqueous solutions, acidic buffers (pH 3–9), and saline solutions that represent the majority of Korean IVD reagent matrices, and strong compliance history in Korean KFDA submissions. Its limitations: PET deforms above 65–70°C (relevant for gamma sterilisation heat loads — usually not a concern since PET is sterilised at room temperature by gamma or EO), PET absorbs UV radiation below 340nm (relevant for UV-sensitive reagents — specify UV-stabilised PET grades for photosensitive diagnostics formulations), and PET should not be used for reagents with organic solvent content above 10% (stress cracking risk).

PETG for Korean medical devices: PETG (polyethylene terephthalate glycol) is preferred for Korean Class II diagnostic kit components where crystal clarity (haze ≤1.5%) is required for colorimetric assay visual interpretation, and for Korean IVD containers requiring snap-break or score-line features that PET’s higher rigidity makes more difficult to achieve. PETG’s lower chemical resistance to certain organic solvents (ethanol above 40%, acetone, MEK) limits its use for Korean laboratory wash solutions and solvent-containing reagents — verify compatibility before specifying PETG for any Korean medical device reagent above 30% organic solvent concentration.

PP for Korean medical devices: Polypropylene is the correct material choice for Korean medical device containers that must withstand steam autoclaving (121°C for 20 minutes) — PET and PETG cannot survive autoclave temperatures. PP ISBM for Korean autoclave-compatible medical device containers requires the PP hot-fill ISBM capability (conditioning 120–145°C, heated mould base inserts) — a more technically demanding and less widely available process than PET ISBM. Korean ISBM producers quoting PP medical device containers should verify their machine’s conditioning station maximum temperature before accepting the contract. The optical clarity requirements that PETG enables for colorimetric applications are addressed in the full guide to Korean ISBM transparency improvement.

4. ISO 10993 Biocompatibility Evaluation: What Korean ISBM Producers Must Provide

ISO 10993-1:2018 (Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process) is the international standard for biocompatibility assessment that Korean KFDA references for all Korean medical device primary packaging. ISO 10993 does not prescribe a fixed test battery — it specifies a risk-based evaluation approach that selects tests according to the device’s nature of contact with the human body (surface contact, breached surface, blood contact) and duration (limited, prolonged, permanent).

For Korean ISBM reagent bottles (Class II IVD, indirect contact with patient — reagent contacts the instrument, not the patient): the biocompatibility evaluation is typically limited to ISO 10993-5 (cytotoxicity) and ISO 10993-12 (sample preparation for biological evaluation). These two tests confirm that the PET or PETG material does not release cytotoxic substances in quantities relevant to indirect patient exposure and that the sample preparation protocol used for any subsequent tests is validated. Total test cost for Korean ISBM Class II IVD reagent bottle: KRW 4–8M at a Korean testing laboratory (Korea Testing and Research Institute — KTR, or Korea Conformity Laboratories — KCL).

For Korean Class III medical device containers (direct contact with patient skin or mucous membrane): the full ISO 10993 evaluation may include cytotoxicity (ISO 10993-5), sensitisation (ISO 10993-10), irritation (ISO 10993-23), acute systemic toxicity (ISO 10993-11), and sub-chronic toxicity (ISO 10993-11 — 90-day study). Total test cost: KRW 25–65M and 6–9 months calendar time. Korean ISBM packaging producers supplying Class III device manufacturers should plan for this evaluation at mould qualification — not at contract award, when the customer has already committed to the packaging specification.

Korean ISBM biocompatibility evaluation documentation requirement: each ISO 10993 test report must identify the specific resin grade (manufacturer, grade designation, lot number), the ISBM process conditions used to produce the test samples (conditioning temperature, blow pressure, cycle time — because process conditions affect extractables levels), and the test laboratory’s KFDA recognition status. A biocompatibility test conducted on samples produced under different process conditions from production samples is not valid for Korean KFDA Class III 허가 submission — a technical detail that catches Korean ISBM producers who use laboratory samples produced at non-standard conditions for the biocompatibility test and then change process conditions during commercial production qualification.

5. Sterilisation Method Compatibility: Korean ISBM Bottle Options and Constraints

Korean medical device containers are sterilised either at the packaging manufacturer (less common for ISBM bottles) or at the Korean medical device company’s filling facility (more common). Korean ISBM packaging producers must understand the sterilisation method the Korean medical device customer will use — because material compatibility, dimensional stability, and optical property retention under the sterilisation conditions vary significantly and determine which Korean ISBM material is technically acceptable.

Korean ISBM producers should request the sterilisation method and validation dose from the Korean medical device customer at the quotation stage — before committing to material specification. A Korean Class II IVD container quoted as crystal-clear PETG for a customer who sterilises by 25 kGy gamma creates a material incompatibility problem that emerges at sterilisation validation, typically 6–8 months after mould manufacture, when the yellowed PETG bottles fail the customer’s post-irradiation clarity specification.

6. Extractables and Leachables: Korean KFDA Expectations for ISBM Medical Containers

Extractables and leachables (E&L) analysis is the most technically demanding documentation requirement for Korean ISBM Class III medical device containers. Extractables are chemical substances that can be liberated from the packaging material under aggressive experimental conditions (elevated temperature, solvent extraction) — they represent the maximum possible chemical exposure from the packaging material. Leachables are the subset of extractables that actually migrate into the product under normal or stressed storage conditions — they represent the actual patient or user exposure from the packaged product.

Korean KFDA E&L expectations for primary container ISBM packaging in Korean Class III medical device 허가 dossiers align with the ISO 10993-18:2020 framework (chemical characterisation of materials) and the PQRI (Product Quality Research Institute) 2006 guideline on leachables and extractables (the industry reference standard that Korean KFDA cites in its medical device submission guidance). The key analytical thresholds Korean ISBM producers must understand:

• Analytical Evaluation Threshold (AET) for Korean Class III IVD: 0.1 μg/day of any compound that cannot be identified — any extractable compound above this concentration in a simulated use extraction must be analytically identified and safety-assessed by a toxicologist. For Korean IVD reagent bottles (indirect patient contact), the AET is typically calculated on the basis of the maximum daily patient dose of the reagent, not direct consumption — allowing higher AET values than for oral drug container E&L.
• PET-specific Korean extractables profile: PET primary extractables are well-characterised: acetaldehyde (AA, thermal degradation product), oligomers (cyclic PET trimer and dimer, process-temperature-dependent), and bis(2-ethylhexyl) phthalate (DEHP — if the PET resin uses DEHP-containing lubricants, which Korean pharmaceutical-grade PET resins do not). Korean medical device applications must specify PET resin from the Korean KFDA-approved food contact positive list and verify with the resin supplier that no phthalate-containing process aids are used.
• Process condition impact on Korean ISBM extractables: Higher barrel temperatures increase PET thermal degradation and AA generation; longer conditioning dwell times increase AA migration from the preform interior to the bottle wall surface. Korean ISBM producers must document the production process conditions used for E&L test sample production and implement change controls preventing future process changes above the validated range — a KFDA Class III requirement that the digital process logging of the Korean ISBM Industry 4.0 framework provides as an automated capability.

7. Cleanroom Production Standards for Korean ISBM Medical Device Packaging

Korean KFDA GMP (의료기기의 제조 및 품질관리 기준) requires medical device manufacturers to establish and maintain clean production environments appropriate to the risk level of the device being manufactured. For Korean primary container ISBM production, the relevant standard is ISO 14644-1 (Cleanrooms and associated controlled environments). Korean ISBM medical device packaging production environment requirements by device class:

• Korean Class I (신고): No formal cleanroom standard required — a general industrial production environment with documented HVAC filtration (MERV 8 or equivalent, replacing standard open factory air intake) and basic housekeeping procedures. Airborne particle monitoring quarterly recommended but not mandatory.
• Korean Class II (인증) — IVD reagent containers: ISO 14644-1 Class 8 production environment (≤ 3,520,000 particles/m³ at ≥ 0.5μm, equivalent to the old US Federal Standard 209E Class 100,000). Practical implementation: HEPA-filtered air supply to the production area, positive pressure differential (≥ +15 Pa) relative to adjacent non-production areas, gowning requirements (hair covers, dust coats, boot covers), and quarterly airborne particle count monitoring per ISO 14644-2.
• Korean Class III (허가) — direct contact device containers: ISO 14644-1 Class 7 production environment (≤ 352,000 particles/m³ at ≥ 0.5μm, equivalent to Class 10,000) for the ISBM machine and bottle ejection zone. Full cleanroom garments (full overalls, gloves, face masks), pass-through material entry with UV decontamination, continuous particle monitoring (real-time alarm at Class 7 limit exceedance), and annual cleanroom performance certification. Korean ISBM operations achieving Class 7 at ISBM ejection zone typically use a local laminar flow hood directly above the bottle ejection conveyor — more economical than building a full Class 7 room around the entire ISBM machine.

8. GMP Validation: IQ, OQ, and PQ for Korean ISBM Medical Device Lines

GMP IQ/OQ/PQ validation is the core of Korean Class III medical device container ISBM qualification. Each phase serves a distinct purpose and generates specific documentation for the KFDA 허가 dossier.

IQ (Installation Qualification): Confirms that the Korean ISBM machine, mould, and ancillary equipment (dryer, chiller, compressed air system) are installed in accordance with manufacturer specifications. IQ documentation for Korean KFDA Class III includes: machine serial number and model confirmation, calibration certificates for all measuring instruments (thermocouples, pressure transducers, weight scales) with KRISS traceability, utility verification (cooling water temperature, flow rate, blow air pressure, dewpoint at machine inlet), and cleanroom environmental measurement at installation (particle count, temperature, humidity, differential pressure). Korean Ever-Power provides machine-specific IQ documentation templates covering all required data fields for Korean KFDA medical device IQ protocol completion.

OQ (Operational Qualification): Determines the validated operating ranges for each critical process parameter by challenging the process at parameter extremes and confirming acceptable product at each level. Typical Korean ISBM OQ study: 3 levels of each critical parameter (nominal − 5%, nominal, nominal + 5%) for conditioning temperature, blow dwell time, and injection fill pressure; 30-bottle samples at each parameter level; dimensional and quality measurements (weight, neck OD, haze, wall thickness at 5 positions, visual inspection) at each level. OQ acceptance criteria: all quality attributes within specification at all parameter levels — establishing the validated parameter ranges within which production must operate. Parameters that produce failing product at nominal ± 5% require the nominal setpoint to be re-optimised and the OQ repeated — a common OQ finding for Korean ISBM Class III producers who have not previously produced to Class III precision tolerances.

PQ (Performance Qualification): Demonstrates that the Korean ISBM process produces consistent specification-compliant product at nominal conditions over a minimum of 3 consecutive production runs at commercial scale. PQ sampling plan: minimum 125 bottles per cavity per run (total 375 per cavity for 3 runs), measured at 9 quality attributes including dimensional measurements, weight, haze, visual inspection per AQL Level II (ANSI/ASQ Z1.4 / ISO 2859-1), and biocompatibility sample production confirmation. PQ statistical analysis: process capability (Cpk) ≥ 1.33 for each critical quality attribute — the Korean KFDA Class III standard for validated manufacturing capability. EV servo ISBM Korean platforms consistently achieve Cpk ≥ 1.50 for bottle weight and neck OD at nominal conditions; hydraulic Korean platforms typically achieve Cpk 1.00–1.20, which is below the Korean Class III standard and necessitates the hydraulic-to-EV-servo upgrade that Korean ISBM producers entering Class III supply consistently encounter as a prerequisite for successful PQ completion.